title: [The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet].
authors.forename: P
authors.initials: P
authors.lastname: Sfriso
authors.forename: F
authors.initials: F
authors.lastname: Salaffi
authors.forename: S
authors.initials: S
authors.lastname: Bombardieri
authors.forename: B
authors.initials: B
authors.lastname: Canesi
authors.forename: C M
authors.initials: CM
authors.lastname: Montecucco
authors.forename: S
authors.initials: S
authors.lastname: Todesco
mesh_terms: D001691:Biological Therapy; D006801:Humans; D020407:Internet; D007558:Italy; D012216:Rheumatic Diseases / Q000188:drug therapy*; D018570:Risk Assessment; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D014409:Tumor Necrosis Factor-alpha